Why Vivos Therapeutics (VVOS) Stock Is Down 25% Today Vivos Therapeutics shares are trading lower by 25% Thursday morning. The company announced a $4.3 million registered offering.
These stocks are moving in today's session Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.
Unusual volume stocks in Wednesday's session Discover the stocks with unexpected trading volume in today's session on the US markets.
Which stocks are experiencing notable movement on Tuesday? Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Let's uncover which stocks are experiencing notable gaps during today's session. Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Gapping stocks in Thursday's session There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Thursday.
Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children The FDA has granted 510(k) clearance to Vivos Therapeutics' DNA oral appliance for treating moderate to severe obstructive sleep apnea and snoring in children aged 6-17.
